Denduluri N - Search Results

1

Systemic therapy for metastatic HER2-positive breast cancer.

Bredin P, Walshe JM, Denduluri N. Bredin P, et al. Among authors: denduluri n. Semin Oncol. 2020 Oct;47(5):259-269. doi: 10.1053/j.seminoncol.2020.07.008. Epub 2020 Aug 18. Semin Oncol. 2020. PMID: 32896428 Review.

2

A pilot study to evaluate the vascular endothelial growth factor receptor tyrosine kinase inhibitor AZD2171 and chemotherapy in locally advanced and inflammatory breast cancer.

Denduluri N, Tan AR, Walshe J, Berman A, Yang SX, Chow CK, Swain SM. Denduluri N, et al. Clin Breast Cancer. 2005 Dec;6(5):460-3. doi: 10.3816/CBC.2005.n.052. Clin Breast Cancer. 2005. PMID: 16381631 No abstract available.

3

A phase II trial with trastuzumab and pertuzumab in patients with HER2-overexpressed locally advanced and metastatic breast cancer.

Walshe JM, Denduluri N, Berman AW, Rosing DR, Swain SM. Walshe JM, et al. Among authors: denduluri n. Clin Breast Cancer. 2006 Feb;6(6):535-9. doi: 10.3816/CBC.2006.n.009. Clin Breast Cancer. 2006. PMID: 16595039 Clinical Trial. No abstract available.

4

Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel.

Cox MC, Low J, Lee J, Walshe J, Denduluri N, Berman A, Permenter MG, Petros WP, Price DK, Figg WD, Sparreboom A, Swain SM. Cox MC, et al. Among authors: denduluri n. Clin Cancer Res. 2006 Aug 1;12(15):4636-40. doi: 10.1158/1078-0432.CCR-06-0388. Clin Cancer Res. 2006. PMID: 16899612

5

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer.

Denduluri N, Lee JJ, Walshe J, Berman AW, Vatas U, Chow CK, Steinberg SM, Cox MC, Low JA, Swain SM. Denduluri N, et al. Invest New Drugs. 2007 Feb;25(1):63-7. doi: 10.1007/s10637-006-9006-7. Epub 2006 Aug 25. Invest New Drugs. 2007. PMID: 16933153 Clinical Trial.

6

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

Walshe JM, Denduluri N, Swain SM. Walshe JM, et al. Among authors: denduluri n. J Clin Oncol. 2006 Dec 20;24(36):5769-79. doi: 10.1200/JCO.2006.07.2793. Epub 2006 Nov 27. J Clin Oncol. 2006. PMID: 17130515 Review.

7

Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes.

Denduluri N, Low JA, Lee JJ, Berman AW, Walshe JM, Vatas U, Chow CK, Steinberg SM, Yang SX, Swain SM. Denduluri N, et al. J Clin Oncol. 2007 Aug 10;25(23):3421-7. doi: 10.1200/JCO.2006.10.0784. Epub 2007 Jul 2. J Clin Oncol. 2007. PMID: 17606971 Clinical Trial.

8

A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer.

Goldman ML, Denduluri N, Berman AW, Sausville R, Guadagnini JP, Kleiner DE, Brahim JS, Swain SM. Goldman ML, et al. Among authors: denduluri n. Oncology. 2006;71(3-4):306-8. doi: 10.1159/000106451. Epub 2007 Jul 26. Oncology. 2006. PMID: 17657174

9

Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer.

Portera CC, Walshe JM, Rosing DR, Denduluri N, Berman AW, Vatas U, Velarde M, Chow CK, Steinberg SM, Nguyen D, Yang SX, Swain SM. Portera CC, et al. Among authors: denduluri n. Clin Cancer Res. 2008 May 1;14(9):2710-6. doi: 10.1158/1078-0432.CCR-07-4636. Clin Cancer Res. 2008. PMID: 18451236 Free PMC article. Clinical Trial.

10

Ixabepilone: clinical role in metastatic breast cancer.

Denduluri N, Swain S. Denduluri N, et al. Clin Breast Cancer. 2011 Jun;11(3):139-45. doi: 10.1016/j.clbc.2011.03.009. Epub 2011 Apr 20. Clin Breast Cancer. 2011. PMID: 21665133 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page